Latest KFF Health News Stories
An estimated 4.8 million people are expected to go without health coverage because Congress did not extend enhanced subsidies for Affordable Care Act plans. But even without a health plan, people will need medical care in 2026. Many of them have been thinking through their plan B to maintain their health.
California Ends Medicaid Coverage of Weight Loss Drugs Despite TrumpRx Plan
Low-income Californians who use Wegovy and similar medications for weight loss lost their coverage at the start of the new year, with officials advising diet and exercise instead. California and other states say the drugs are too costly, even as the Trump administration announces plans to lower prices.
Seis tips para obtener fármacos que previenen el VIH superando obstáculos del sistema de salud
Los CDC calculan que 2,2 millones de personas en Estados Unidos podrían beneficiarse del uso de medicamentos preventivos contra el VIH, pero solo poco más de una cuarta parte los recibe.
Older Americans Quit Weight Loss Drugs in Droves
In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side effects.
To Knock Down Health-System Hurdles Between You and HIV Prevention, Try These 6 Things
It’s been more than 10 years since the FDA first approved an HIV prevention drug. Today, people who could benefit from preexposure prophylaxis often struggle to access the lifesaving medicine or run into doctors without the education or empathy to offer affirming care. And those lapses can produce billing headaches.
FDA’s Plan To Boost Biosimilar Drugs Could Stall at the Patent Office
Drug industry officials and analysts praised the FDA’s plans to streamline regulation of “biosimilars,” which are cheaper alternatives to biologic drugs. But patents that block such drugs from the U.S. market are getting harder to fight.
What the Health? From KFF Health News: Schrödinger’s Government Shutdown
Democrats and Republicans remain stalled over funding the federal government as Republicans launch a new attack on the Affordable Care Act. Meanwhile, the Trump administration is taking advantage of the shutdown to lay off workers from programs supported mostly by Democrats. Anna Edney of Bloomberg News, Lauren Weber of The Washington Post, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews health insurance analyst Louise Norris about Medicare open enrollment.
In Mississippi, Medicaid Coverage of Weight Loss Drugs Fails To Catch On
In Mississippi, a state with one of the highest obesity rates in the nation, Medicaid covers weight loss drugs, but few enrollees have signed up for the benefit.
Listen: Why ‘TrumpRx’ Might Not Save You Money
On the “Today, Explained” podcast, KFF Health News’ Julie Rovner recaps the TrumpRx announcement and why the direct-to-consumer initiative may not save you money on prescription drugs if you have insurance through your employer or the government.
What the Health? From KFF Health News: Democrats Make This Shutdown About the ACA
The foreshadowed federal shutdown came after Congress failed to pass required spending bills, with Democrats demanding Republicans renew the expiring Affordable Care Act subsidies in exchange for their votes. While a shutdown does not affect Medicare and Medicaid, it could eventually hinder activities from every corner of the Department of Health and Human Services. Meanwhile, as Democrats and Republicans point fingers, HHS Secretary Robert F. Kennedy Jr. pursues policies and personnel that would undermine vaccines. Lauren Weber of The Washington Post, Shefali Luthra of The 19th, and Rachel Cohrs Zhang of Bloomberg News join KFF Health News’ Julie Rovner to discuss the news. Also this week, Rovner interviews KFF Health News’ Cara Anthony, who wrote a recent “Bill of the Month” feature about an out-of-network eye surgery that left one kindergartner’s family with a big bill.
In a rambling news conference that shocked public health experts, President Donald Trump — without scientific evidence — blamed the over-the-counter drug acetaminophen, and too many childhood vaccines, for the increase in autism diagnoses in the U.S. That came days after a key immunization advisory panel, newly reconstituted with vaccine doubters, changed several long-standing recommendations. Former Centers for Disease Control and Prevention official Demetre Daskalakis joins KFF Health News’ Julie Rovner to discuss those stories. Meanwhile, Sandhya Raman of CQ Roll Call and Anna Edney of Bloomberg News join Rovner with the rest of the news, including a threat by the Trump administration to fire rather than furlough federal workers if Congress fails to fund the government beyond the Oct. 1 start of the new fiscal year.
As Insurers Struggle With GLP-1 Drug Costs, Some Seek To Wean Patients Off
Conventional wisdom says GLP-1 drugs must be taken indefinitely to maintain weight loss. But a growing number of researchers, payers, and providers are challenging that consensus and exploring whether — and how — to taper patients off expensive GLP-1 drugs.
Breaking Down Why Medicare Part D Premiums Are Likely To Go Up
Insurers will take drug costs, frequency of use, and other factors into account as they set premium amounts for the 2026 plan year.
Why Young Americans Dread Turning 26: Health Insurance Chaos
Young adults without jobs that provide insurance find their options are limited and expensive. The problem is about to get worse.
A Guide To Finding Insurance at 26
It’s a difficult rite of passage for young adults without job-based insurance. Here are some tips for getting started.
What the Health? From KFF Health News: Kennedy Cancels Vaccine Funding
The Health and Human Services secretary is winding down nearly $500 million in mRNA research funding, citing false claims that the technology is ineffective against respiratory illnesses — and notching a victory for critics of the covid vaccines. And President Donald Trump is demanding drugmakers drop their prices, quickly, but it’s unclear how he could make them comply. Lauren Weber of The Washington Post, Sandhya Raman of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Emmarie Huetteman to discuss these stories and more.
A Tourist Ended Up With a Wild Bat in Her Mouth — And Nearly $21,000 in Medical Bills
Health insurance generally doesn’t cover treatment for injuries sustained shortly before a customer buys a policy. A Massachusetts woman found that out the hard way.
An Arm and a Leg: The Prescription Drug Playbook, Part II
In this second part of a two-part series on dealing with the high price of prescription drugs, experts share their insider tips.
An Arm and a Leg: The Prescription Drug Playbook, Part I
In Part 1 of a two-part series on dealing with the high price of prescription drugs, a father explains the strategies he used to get his daughter the medicine she needs to treat her epilepsy.
Trump Exaggerates Speed and Certainty of Prescription Drug Price Reductions
According to the timeline in the May 12 executive order, prescription drug price reductions would not happen “almost immediately,” but rather could take months or years. And extending the savings to Americans outside federal health insurance programs such as Medicare would likely require congressional action.
